The Role of Hematological Inflammatory Biomarkers in the Diagnosis of Lung Cancer and in Predicting TNM Stage

References

• Barta JA, Powell CA, Wisnivesky JP. Global epidemiology of lung cancer. Ann Glob Health. 2019;85(1):8.
   PubMed Web of Science ®Google Scholar
• Yin Y, Wang J, Wang X, Gu L, Pei H, Kuai S, et al. Prognostic value of the neutrophil to lymphocyte ratio in lung cancer: a meta-analysis. Clinics. 2015;70(7):524–530.
   PubMed Web of Science ®Google Scholar
• Wood DE, Kazerooni EA, Baum SL, Eapen GA, Ettinger DS, Hou L, et al. Lung cancer screening, version 3.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2018;16(4):412–441.
   PubMed Web of Science ®Google Scholar
• Ethier J-L, Desautels D, Templeton A, Shah PS, Amir E. Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis. Breast Cancer Res. 2017;19(1):2.
   PubMed Web of Science ®Google Scholar
• Kılınçalp S, Ekiz F, Başar Ö, Ayte MR, Çoban Ş, Yılmaz B, et al. Mean platelet volume could be possible biomarker in early diagnosis and monitoring of gastric cancer. Platelets. 2014;25(8):592–594.
   PubMed Web of Science ®Google Scholar
• Zhang H, Zhang L, Zhu K, Shi B, Yin Y, Zhu J, et al. Prognostic significance of combination of preoperative platelet count and neutrophil-lymphocyte ratio (COP-NLR) in patients with non-small cell lung cancer: based on a large cohort study. PLoS One. 2015;10(5):e0126496.
   PubMed Web of Science ®Google Scholar
• Faria SS, Fernandes PC, Jr., Silva MJ, Lima VC, Fontes W, Freitas-Junior R, et al. The neutrophil-to-lymphocyte ratio: a narrative review. Ecancer. 2016;10:702.
   PubMed Web of Science ®Google Scholar
• Sylman JL, Mitrugno A, Atallah M, Tormoen GW, Shatzel JJ, Tassi Yunga S, et al. The predictive value of inflammation-related peripheral blood measurements in cancer staging and prognosis. Front Oncol. 2018;8:78.
   PubMedGoogle Scholar
• Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WE, et al., International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee Advisory Boards and Participating Institutions. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol. 2016;11(1):39–51.
   PubMed Web of Science ®Google Scholar
• Huang W-Y, Berndt SI, Shiels MS, Katki HA, Chaturvedi AK, Wentzensen N, et al. Circulating inflammation markers and colorectal adenoma risk. Carcinogenesis. 2019;40(6):765–770.
   PubMed Web of Science ®Google Scholar
• Templeton AJ, McNamara MG, Šeruga B, Vera-Badillo FE, Aneja P, Ocaña A, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. JNCI. 2014;106(6):dju124.
   Google Scholar
• Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19(11):1423–1437.
   PubMed Web of Science ®Google Scholar
• Jurasz P, Alonso ‐Escolano D, Radomski MW. Platelet–cancer interactions: mechanisms and pharmacology of tumour cell‐induced platelet aggregation. Br J Pharmacol . 2004;143(7):819–826.
   PubMed Web of Science ®Google Scholar
• Mangalpally KKR, Siqueiros-Garcia A, Vaduganathan M, Dong J-F, Kleiman NS, Guthikonda S. Platelet activation patterns in platelet size sub-populations: differential responses to aspirin in vitro. J Thromb Thrombolysis. 2010; 30(3):251–262.
   PubMed Web of Science ®Google Scholar
• Afsar CU, Gunaldi M, Kum P, Sahin B, Erkisi M, Kara IO, et al. Pancreatic carcinoma, thrombosis and mean platelet volume: single center experience from the southeast region of Turkey. Asian Pac J Cancer Prev. 2014; 15(21):9143–9146.
   PubMedGoogle Scholar
• Baldane S, Ipekci SH, Sozen M, Kebapcilar L. Mean platelet volume could be a possible biomarker for papillary thyroid carcinomas. Asian Pac J Cancer Prev. 2015;16(7):2671–2674.
   PubMedGoogle Scholar
• Zhu X, Chen Y, Cui Y. Absolute neutrophil count and mean platelet volume in the blood as biomarkers to detect lung cancer. Dis Markers. 2020;2020:1–5.
   Web of Science ®Google Scholar
• Kucuk H, Tecer D, Goker B, Varan O, Babaoglu H, Guven SC, et al. Platelet/lymphocyte ratio and mean platelet volume in patients with granulomatosis with polyangiitis. Adv Rheumatol. 2020;60(1):4.
   Google Scholar
• Kulaksızoğlu S, Merter AA. Neutrophil/lymphocyte, platelet/lymphocyte and platelet large cell ratio values in the diagnosis of colorectal cancer patients. Fırat Univ Med J Health Sci. 2019;33(3):169–173.
   Google Scholar
• Nash G, Turner L, Scully M, Kakkar A. Platelets and cancer. Lancet Oncol. 2002;3(7):425–430.
   PubMed Web of Science ®Google Scholar
• Huang Q, Diao P, Li CL, Peng Q, Xie T, Tan Y, et al. Preoperative platelet-lymphocyte ratio is a superior prognostic biomarker to other systemic inflammatory response markers in non-small cell lung cancer. Medicine. 2020;99(4):e18607.
   PubMed Web of Science ®Google Scholar
• Wang X, Cui M-M, Xu Y, Liu L, Niu Y, Liu T, et al. Decreased mean platelet volume predicts poor prognosis in invasive bladder cancer. Oncotarget. 2017;8(40):68115–68122.
   PubMedGoogle Scholar
• Omar M, Tanriverdi O, Cokmert S, Oktay E, Yersal O, Pilancı KN, et al., Turkish Descriptive Oncological Researches Group. Role of increased mean platelet volume (MPV) and decreased MPV/platelet count ratio as poor prognostic factors in lung cancer. Clin Respir J. 2018;12(3):922–929.
   PubMed Web of Science ®Google Scholar
• Xu F, Xu P, Cui W, Gong W, Wei Y, Liu B, et al. Neutrophil‑to‑lymphocyte and platelet‑to‑lymphocyte ratios may aid in identifying patients with non‑small cell lung cancer and predicting tumor‑node‑metastasis stages. Oncol Lett. 2018; 16(1):483–490.
   PubMed Web of Science ®Google Scholar
• Cukic V. Neutrophil/Lymphocyte ratio and platelet/lymphocyte ratio in patients with NSCLC. Mater Sociomed. 2016;28(5):378.
   PubMedGoogle Scholar